You are currently viewing a new version of our website. To view the old version click .

Non-Coding RNA, Volume 10, Issue 5

October 2024 - 7 articles

Cover Story: Lung cancer remains a leading cause of cancer-related deaths worldwide, largely due to late-stage diagnoses and aggressive disease progression. Despite advancements, the prognosis for lung cancer patients remains poor. Emerging research highlights non-coding RNAs (ncRNAs)—including microRNAs, long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs)—as key regulators of gene expression, influencing tumor development, progression, metastasis, and treatment resistance. This review explores the potential of ncRNAs as biomarkers for early diagnoses, prognoses, and predictions of therapeutic responses in lung cancer. Advances in ncRNA-based therapies offer promising avenues for personalized treatment, although challenges like delivery and large-scale validation remain. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (7)

  • Review
  • Open Access
8 Citations
5,895 Views
8 Pages

MicroRNA Biogenesis, Gene Regulation Mechanisms, and Availability in Foods

  • Amilton S. de Mello,
  • Bradley S. Ferguson,
  • Erica L. Shebs-Maurine and
  • Francine M. Giotto

11 October 2024

MicroRNAs (miRNAs) are small, non-coding RNAs that control gene expression by degrading or repressing mRNA translation into proteins. Research recently suggested that food-derived miRNAs are bioavailable and may be absorbed in the gastrointestinal tr...

  • Review
  • Open Access
2 Citations
2,191 Views
24 Pages

30 September 2024

Epithelial ovarian cancer (EOC) with its high death incidence rate is generally detected at advanced stages. During its progression, EOC often develops peritoneal metastasis aggravating the outcomes of EOC patients. Studies on non-coding RNAs (ncRNAs...

  • Review
  • Open Access
14 Citations
3,686 Views
25 Pages

Non-Coding RNA as a Biomarker in Lung Cancer

  • Chahat Suri,
  • Shashikant Swarnkar,
  • LVKS Bhaskar and
  • Henu Kumar Verma

30 September 2024

Introduction: Lung cancer remains one of the most prevalent and deadly cancers globally, with high mortality rates largely due to late-stage diagnosis, aggressive progression, and frequent recurrence. Despite advancements in diagnostic techniques and...

  • Review
  • Open Access
8 Citations
3,746 Views
20 Pages

Back to the Origin: Mechanisms of circRNA-Directed Regulation of Host Genes in Human Disease

  • Haomiao Yuan,
  • Xizhou Liao,
  • Ding Hu,
  • Dawei Guan and
  • Meihui Tian

24 September 2024

Circular RNAs (circRNAs) have been shown to be pivotal regulators in various human diseases by participating in gene splicing, acting as microRNA (miRNA) sponges, interacting with RNA-binding proteins (RBPs), and translating into short peptides. As t...

  • Article
  • Open Access
6 Citations
3,747 Views
16 Pages

2 September 2024

Following the acute phase of SARS-CoV-2 infection, certain individuals experience persistent symptoms referred to as long COVID. This study analyzed the patients categorized into three distinct groups: (1) individuals presenting rheumatological sympt...

  • Article
  • Open Access
5 Citations
2,441 Views
14 Pages

The Circulating miR-107 as a Potential Biomarker Up-Regulated in Castration-Resistant Prostate Cancer

  • Jonathan Puente-Rivera,
  • David Alejandro De la Rosa Pérez,
  • Stephanie I. Nuñez Olvera,
  • Elisa Elvira Figueroa-Angulo,
  • José Gadú Campos Saucedo,
  • Omar Hernández-León and
  • María Elizbeth Alvarez-Sánchez

Prostate cancer (PCa) is a prevalent malignancy in men globally. Current diagnostic methods like PSA testing have limitations, leading to overdiagnosis and unnecessary treatment. Castration-resistant prostate cancer (CRPC) emerges in some patients re...

  • Article
  • Open Access
1 Citations
3,240 Views
19 Pages

MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study

  • Ennio Nano,
  • Francesco Reggiani,
  • Adriana Agnese Amaro,
  • Paola Monti,
  • Monica Colombo,
  • Nadia Bertola,
  • Fabiana Ferrero,
  • Franco Fais,
  • Antonella Bruzzese and
  • Enrica Antonia Martino
  • + 14 authors

A “watch and wait” strategy, delaying treatment until active disease manifests, is adopted for most CLL cases; however, prognostic models incorporating biomarkers have shown to be useful to predict treatment requirement. In our prospectiv...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Non-Coding RNA - ISSN 2311-553X